{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:18:59Z","timestamp":1790475539697,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association Inc.","doi-asserted-by":"publisher","award":["KOT-1819"],"award-info":[{"award-number":["KOT-1819"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association Inc.","doi-asserted-by":"publisher","award":["KOT-2021"],"award-info":[{"award-number":["KOT-2021"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association Inc.","doi-asserted-by":"publisher","award":["575466"],"award-info":[{"award-number":["575466"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-156379"],"award-info":[{"award-number":["PJT-156379"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ebiom.2020.102750","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T03:45:47Z","timestamp":1587699947000},"page":"102750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy"],"prefix":"10.1016","volume":"55","author":[{"given":"Marc-Olivier","family":"Deguise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"De Repentigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Tierney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Beauvais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Michaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Chehade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Thabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Kothary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2020.102750_bib0001","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy- determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102750_bib0002","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","article-title":"Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review","volume":"12","author":"Verhaart","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102750_bib0003","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy","volume":"70","author":"Feldkotter","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ebiom.2020.102750_bib0004","series-title":"Spinal muscular atrophy: disease mechanisms and therapy","first-page":"3","article-title":"Spinal muscular atrophy: 125 years later and on the verge of a cure","author":"Oskoui","year":"2017"},{"issue":"10063","key":"10.1016\/j.ebiom.2020.102750_bib0005","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study","volume":"388","author":"Finkel","year":"2016","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.ebiom.2020.102750_bib0006","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ebiom.2020.102750_bib0007","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2020.102750_bib0008","series-title":"Spinal muscular atrophy: disease mechanisms and therapy","first-page":"241","article-title":"Mammalian models of spinal muscular atrophy","author":"Burghes","year":"2017"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102750_bib0009","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/71709","article-title":"A mouse model for spinal muscular atrophy","volume":"24","author":"Hsieh-Li","year":"2000","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102750_bib0010","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/hmg\/ddi078","article-title":"SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN","volume":"14","author":"Le","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102750_bib0011","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","article-title":"The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-\/-) mice and results in a mouse with spinal muscular atrophy","volume":"9","author":"Monani","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102750_bib0012","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.nmd.2011.09.007","article-title":"A critical SMN threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology","volume":"22","author":"Bowerman","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"23","key":"10.1016\/j.ebiom.2020.102750_bib0013","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1093\/hmg\/10.23.2727","article-title":"Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing","volume":"10","author":"DiDonato","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102750_bib0014","doi-asserted-by":"crossref","first-page":"e15887","DOI":"10.1371\/journal.pone.0015887","article-title":"Mouse survival motor neuron alleles that mimic SMN2 splicing and are inducible rescue embryonic lethality early in development but not late","volume":"5","author":"Hammond","year":"2010","journal-title":"PLoS ONE"},{"issue":"20","key":"10.1016\/j.ebiom.2020.102750_bib0015","first-page":"4494","article-title":"Effect of genetic background on the phenotype of the Smn2B\/- mouse model of spinal muscular atrophy","volume":"25","author":"Eshraghi","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"43","key":"10.1016\/j.ebiom.2020.102750_bib0016","doi-asserted-by":"crossref","first-page":"E5863","DOI":"10.1073\/pnas.1509758112","article-title":"Systemic, postsymptomatic antisense oligonucleotide rescues motor unit maturation delay in a new mouse model for type II\/III spinal muscular atrophy","volume":"112","author":"Bogdanik","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102750_bib0017","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1093\/hmg\/ddt037","article-title":"Development and characterization of an SMN2-based intermediate mouse model of spinal muscular atrophy","volume":"22","author":"Cobb","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"21","key":"10.1016\/j.ebiom.2020.102750_bib0018","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1093\/hmg\/ddq343","article-title":"A humanized Smn gene containing the SMN2 nucleotide alteration in exon 7 mimics SMN2 splicing and the SMA disease phenotype","volume":"19","author":"Gladman","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102750_bib0019","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1083\/jcb.200208079","article-title":"A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy","volume":"160","author":"Monani","year":"2003","journal-title":"J Cell Biol"},{"issue":"20","key":"10.1016\/j.ebiom.2020.102750_bib0020","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1093\/hmg\/dds285","article-title":"Characterization of behavioral and neuromuscular junction phenotypes in a novel allelic series of SMA mouse models","volume":"21","author":"Osborne","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102750_bib0021","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.nbd.2006.07.004","article-title":"Establishing a standardized therapeutic testing protocol for spinal muscular atrophy","volume":"24","author":"Tsai","year":"2006","journal-title":"Neurobiol Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102750_bib0022","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1093\/hmg\/ddp157","article-title":"A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice","volume":"18","author":"Workman","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102750_bib0023","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nbd.2011.03.002","article-title":"Characterization of a commonly used mouse model of SMA reveals increased seizure susceptibility and heightened fear response in FVB\/N mice","volume":"43","author":"Gogliotti","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102750_bib0024","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1021\/pr9006987","article-title":"Identification of novel interacting protein partners of SMN using tandem affinity purification","volume":"9","author":"Shafey","year":"2010","journal-title":"J Proteome Res"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102750_bib0025","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/acn3.50855","article-title":"Abnormal fatty acid metabolism is a core component of spinal muscular atrophy","volume":"6","author":"Deguise","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102750_bib0026","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2020.102750_bib0027","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0022-2275(20)40190-7","article-title":"Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride\u2013methanol","volume":"5","author":"Morrison","year":"1964","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102750_bib0028","doi-asserted-by":"crossref","first-page":"C1464","DOI":"10.1152\/ajpcell.00278.2003","article-title":"KATP channels depress force by reducing action potential amplitude in mouse EDL and soleus muscle","volume":"285","author":"Gong","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"issue":"7367","key":"10.1016\/j.ebiom.2020.102750_bib0029","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature10485","article-title":"Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model","volume":"478","author":"Hua","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102750_bib0030","first-page":"801","article-title":"Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice","volume":"26","author":"Deguise","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"16","key":"10.1016\/j.ebiom.2020.102750_bib0031","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1093\/hmg\/ddu142","article-title":"Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy","volume":"23","author":"Boyer","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ebiom.2020.102750_bib0032","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mcn.2015.11.007","article-title":"Central and peripheral defects in motor units of the diaphragm of spinal muscular atrophy mice","volume":"70","author":"Neve","year":"2016","journal-title":"Mol Cell Neurosci"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102750_bib0033","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/acn3.423","article-title":"New insights into SMA pathogenesis: immune dysfunction and neuroinflammation","volume":"4","author":"Deguise","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102750_bib0034","first-page":"932","article-title":"SMN deficiency negatively impacts red pulp macrophages and spleen development in mouse models of spinal muscular atrophy","volume":"26","author":"Khairallah","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102750_bib0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/joa.12546","article-title":"Survival of motor neurone protein is required for normal postnatal development of the spleen","volume":"230","author":"Thomson","year":"2017","journal-title":"J Anat"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102750_bib0036","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/1531-8249(199903)45:3<337::AID-ANA9>3.0.CO;2-U","article-title":"Abnormal fatty acid metabolism in childhood spinal muscular atrophy","volume":"45","author":"Crawford","year":"1999","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102750_bib0037","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0887-8994(94)00100-G","article-title":"Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)?","volume":"12","author":"Tein","year":"1995","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102750_bib0038","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ejpn.2012.01.004","article-title":"Abnormal fatty acid metabolism in spinal muscular atrophy may predispose to perioperative risks","volume":"16","author":"Zolkipli","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102750_bib0039","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/ana.410200615","article-title":"Dicarboxylic aciduria in an infant with spinal muscular atrophy","volume":"20","author":"Kelley","year":"1986","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.ebiom.2020.102750_bib0040","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/jmg.2008.057950","article-title":"Congenital heart disease is a feature of severe infantile spinal muscular atrophy","volume":"45","author":"Rudnik-Schoneborn","year":"2008","journal-title":"J Med Genet"},{"issue":"20","key":"10.1016\/j.ebiom.2020.102750_bib0041","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1093\/hmg\/ddq300","article-title":"Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery","volume":"19","author":"Bevan","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"20","key":"10.1016\/j.ebiom.2020.102750_bib0042","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1093\/hmg\/ddq330","article-title":"Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice","volume":"19","author":"Heier","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102750_bib0043","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.yjmcc.2012.01.005","article-title":"Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy","volume":"52","author":"Shababi","year":"2012","journal-title":"J Mol Cell Cardiol"},{"issue":"20","key":"10.1016\/j.ebiom.2020.102750_bib0044","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1093\/hmg\/ddq329","article-title":"Cardiac defects contribute to the pathology of spinal muscular atrophy models","volume":"19","author":"Shababi","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102750_bib0045","first-page":"175","article-title":"Cardiac involvement in patients with spinal muscular atrophies","volume":"30","author":"Palladino","year":"2011","journal-title":"Acta Myol"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102750_bib0046","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2009.08.002","article-title":"A positive modifier of spinal muscular atrophy in the SMN2 gene","volume":"85","author":"Prior","year":"2009","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102750_bib0047","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/hmg\/9.3.341","article-title":"Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III","volume":"9","author":"Jablonka","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102750_bib0048","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/hmg\/ddp562","article-title":"Ciliary neurotrophic factor-induced sprouting preserves motor function in a mouse model of mild spinal muscular atrophy","volume":"19","author":"Simon","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.1016\/j.ebiom.2020.102750_bib0049","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/emmm.201302567","article-title":"Pathological impact of SMN2 mis-splicing in adult SMA mice","volume":"5","author":"Sahashi","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ebiom.2020.102750_bib0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40478-015-0231-1","article-title":"Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn (2b\/-) mouse model of spinal muscular atrophy","volume":"3","author":"Murray","year":"2015","journal-title":"Acta Neuropathol Commun"},{"issue":"13","key":"10.1016\/j.ebiom.2020.102750_bib0051","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1016\/j.celrep.2017.12.003","article-title":"Converging mechanisms of p53 activation drive motor neuron degeneration in spinal muscular atrophy","volume":"21","author":"Simon","year":"2017","journal-title":"Cell Rep"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102750_bib0052","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41419-019-1727-6","article-title":"Reduced P53 levels ameliorate neuromuscular junction loss without affecting motor neuron pathology in a mouse model of spinal muscular atrophy","volume":"10","author":"Courtney","year":"2019","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102750_bib0053","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0960-8966(96)00350-1","article-title":"Discordant clinical outcome in type iii spinal muscular atrophy sibships showing the same deletion pattern","volume":"6","author":"Capon","year":"1996","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102750_bib0054","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/archneur.1968.00480020042004","article-title":"Kugelberg-Welander disease with particular reference to sex-influenced manifestations","volume":"19","author":"Furukawa","year":"1968","journal-title":"Arch Neurol"},{"issue":"10","key":"10.1016\/j.ebiom.2020.102750_bib0055","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/4.10.1927","article-title":"Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals","volume":"4","author":"Hahnen","year":"1995","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102750_bib0056","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/jmg.22.5.350","article-title":"Chronic proximal spinal muscular atrophy of childhood and adolescence: problems of classification and genetic counselling","volume":"22","author":"Hausmanowa-Petrusewicz","year":"1985","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102750_bib0057","doi-asserted-by":"crossref","first-page":"103","DOI":"10.18388\/abp.2009_2521","article-title":"Phenotype modifiers of spinal muscular atrophy: the number of SMN2 gene copies, deletion in the NAIP gene and probably gender influence the course of the disease","volume":"56","author":"Jedrzejowska","year":"2009","journal-title":"Acta Biochim Pol"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102750_bib0058","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","article-title":"Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications","volume":"52","author":"Zerres","year":"1995","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102750_bib0059","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00439-003-1025-2","article-title":"Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1","volume":"114","author":"Helmken","year":"2003","journal-title":"Hum Genet"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102750_bib0060","first-page":"805","article-title":"Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy","volume":"57","author":"Cobben","year":"1995","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102750_bib0061","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00415-005-0912-y","article-title":"SMN2 copy number predicts acute or chronic spinal muscular atrophy but does not account for intrafamilial variability in siblings","volume":"253","author":"Cusco","year":"2006","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102750_bib0062","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/hmg\/5.3.359","article-title":"Characterization of survival motor neuron (SMNT) gene deletions in asymptomatic carriers of spinal muscular atrophy","volume":"5","author":"Wang","year":"1996","journal-title":"Hum Mol Genet"},{"issue":"5875","key":"10.1016\/j.ebiom.2020.102750_bib0063","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.1155085","article-title":"Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy","volume":"320","author":"Oprea","year":"2008","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.ebiom.2020.102750_bib0064","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/archneurol.2010.239","article-title":"Association of plastin 3 expression with disease severity in spinal muscular atrophy only in postpubertal females","volume":"67","author":"Stratigopoulos","year":"2010","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102750_bib0065","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI72017","article-title":"Requirement of enhanced survival motoneuron protein imposed during neuromuscular junction maturation","volume":"124","author":"Kariya","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2020.102750_bib0066","doi-asserted-by":"crossref","DOI":"10.1172\/JCI131989","article-title":"Muscle-specific SMN reduction reveals motor neuron-independent disease in spinal muscular atrophy models","author":"Kim","year":"2020","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102750_bib0067","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/2044-5040-3-24","article-title":"Early onset muscle weakness and disruption of muscle proteins in mouse models of spinal muscular atrophy","volume":"3","author":"Boyer","year":"2013","journal-title":"Skelet Muscle"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102750_bib0068","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1523\/JNEUROSCI.4434-08.2009","article-title":"Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice","volume":"29","author":"Kong","year":"2009","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102750_bib0069","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/brain\/101.4.591","article-title":"A clinical and genetic study of spinal muscular atrophy of adult onset: the autosomal recessive form as a discrete disease entity","volume":"101","author":"Pearn","year":"1978","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2020.102750_bib0070","series-title":"Spinal muscular atrophy: disease mechanisms and therapy","first-page":"167","article-title":"Contributions of different cell types to spinal muscular atrophy pathogenesis","author":"Deguise","year":"2017"},{"issue":"22","key":"10.1016\/j.ebiom.2020.102750_bib0071","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1093\/hmg\/ddv329","article-title":"Repeated low doses of morpholino antisense oligomer: an intermediate mouse model of spinal muscular atrophy to explore the window of therapeutic response","volume":"24","author":"Zhou","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102750_bib0072","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/hmg\/ddv629","article-title":"Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset","volume":"25","author":"Feng","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102750_bib0073","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/hmg\/ddy382","article-title":"Specific inhibition of myostatin activation is beneficial in mouse models of SMA therapy","volume":"28","author":"Long","year":"2019","journal-title":"Hum Mol Genet"}],"updated-by":[{"DOI":"10.1016\/j.ebiom.2021.103295","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000}}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420301250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420301250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T01:03:24Z","timestamp":1715043804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420301250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":73,"alternative-id":["S2352396420301250"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102750","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ebiom.2021.103295","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102750"}}